Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-07-03

Clinical Trial Update: Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of artemether-lumefantrine tablets in African infants and children with uncomplicated Plasmodium falciparum mal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coartem (artemether-lumefantrine)

Snippet

Sponsor: Novartis | Conditions: Plasmodium Falciparum Malaria | Phase 3 | Status: COMPLETED